India's leading pharma company fell sharply in early deals today
Advertisement
Advertisement
Cipla said its first quarter net profit surged 120 percent to 651 crore rupees compared with 295 crore rupees in the same quarter a year ago. Sales during April-June jumped 43 percent to 3,777 crore rupees versus 2,647 crore rupees in the same period last year.
The strong performance was ignored by traders who preferred to press the Sell button on the stock.
As a result, Cipla fell 29.60 rupees, or 4 percent, to 710 rupees on the
Cipla's market capitalisation has soared 58 percent in the past one year to 59,460 crore rupees as investors bought into the growing exports story and the relative safety of sales and profit of pharma companies.
Advertisement
(Image credits: Indiatimes)
Advertisement
- I spent 2 weeks in India. A highlight was visiting a small mountain town so beautiful it didn't seem real.
- I quit McKinsey after 1.5 years. I was making over $200k but my mental health was shattered.
- Some Tesla factory workers realized they were laid off when security scanned their badges and sent them back on shuttles, sources say
- Indian Railways to break record with 9,111 trips to meet travel demand this summer, nearly 3,000 more than in 2023
- India's exports to China, UAE, Russia, Singapore rose in 2023-24
- A case for investing in Government securities
- Top places to visit in Auli in 2024
- Sustainable Transportation Alternatives